etanercept Solution
for Subcutaneous Use Initial U.S. Approval: 1998

Facts about etanercept Solution

Approval Date: 2018
Proprietary Name: On Request
Active Ingredient(s): etanercept
Dosage Forms And Strengths:

• 50 mg Single-use Prefilled Syringe
  0.98 mL of a 50 mg/mL solution of etanercept
• 50 mg Single-use Prefilled SureClick® Autoinjector
  0.98 mL of a 50 mg/mL solution of etanercept
• 25 mg Single-use Prefilled Syringe
  0.51 mL of a 50 mg/mL solution of etanercept
• 25 mg Multiple-use Vial
  25 mg of etanercept

Company: Amgen
Diseases: rheumatoid arthritis, plaque psoriasis, psoriatic arthritis, ankylosing spondylitis and juvenile idiopathic arthritis
Medicine Approved By: – European Medical Agency (EMA), Food and Drug Administration (FDA), Health Canada, Therapeutic Goods Administration (TGA), Medsafe (NZ)
Summary of FDA approved use on approval date: Click Here
(see Drugs@FDA for complete indication)

Access the best support services globally

If you have a prescription from a Registered Medical Practitioner (RMP), IPN in Delhi can assist you in obtaining access to genuine medication.  Our professional will provide you with a step-by-step guide on how to legally and safely import “etanercept Solution” based on the information you provide.

Indian Pharma Network (IPN) Legitimate consultant and facilitator in the New Delhi, India. IPN has over two decades of industry experience and extensive coverage throughout India, including major cities such as Mumbai, Kolkata, Hyderabad, Chennai, Ahmedabad, Delhi, Bangalore, Srinagar, Jammu, Jaipur, Chandigarh, Ludhiana, Noida, Gurgaon, Lucknow, the North East, Pune, and other regions.